Ocular disorders comprising various diseases of the anterior and posterior segments are
considered as the main reasons for blindness. Natural products have been identified as …

Introduction Ocular barriers hinder drug delivery and reduce drug bioavailability. This article
focuses on enhancing drug absorption across the corneal and conjunctival epithelium. Both …

Uveal melanoma (UM) is the most common primary intraocular tumor in adults with high
mortality. In order to improve prognosis and survival of UM patients, it is critical to inhibit …

Damage to the retinal pigment epithelium, Bruch's membrane and/or tissues underlying
macula is known to increase the risk of age-related macular degeneration (AMD). AMD is …

Age-related macular degeneration (AMD) is a multifactorial disease associated with
anatomical changes in the inner retina. Despite tremendous advances in clinical care, there …

Introduction: Diabetic retinopathy (DR) is associated with damage to the retinal blood
vessels that lead eventually to vision loss. The existing treatments of DR are invasive …

Age-related macular degeneration (AMD), a degenerative eye disease, is the major cause of
irreversible loss of vision among individuals aged 50 and older. Both genetic and …

The retina may suffer neurodegenerative damages, as other tissues of the central nervous
system do, and serious eye diseases may develop. One of them is age-related macular …

Blindness affects more than 60 million people worldwide. Retinal disorders, including age-
related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma, are the …

The purpose of this study was to explore the potential of formulating hesperetin into an
ophthalmic solution with dipotassium glycyrrhizinate (DG) as a micelle nanocarrier. A DG …